Skip to main content
FDA okays 1-month dual antiplatelet therapy for Abbott’s Xience stents
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA okays 1-month dual antiplatelet therapy for Abbott’s Xience stents
User login
Username
Password
Reset your password
Specialty
Lead
score
Cardiology
1
1
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.9
Concept
Lead
score
Stent
0
1
Food and Drug Administration (FDA)
0
0.9
Myocardial Infarction (MI)
0
0.29
Thromboembolism
0
0.29
Europe
0
0.24
Blood Vessel
0
0.17
Thrombus
0
0.17
Blood
0
0.16
Grant
0
0.16
Aspirin
0
0.08
Calcaneal
0
0.08
Hemorrhage
0
0.08
Infarction
0
0.08
New York
0
0.08